Biochemistry
-
Research Snapshot: Development of a new framework and tool for multi-drug synergy and combination
MuSyC is a technique to help researchers devise new combinations of drugs. An open-source analysis tool, it holds the promise speed such discoveries around the world. Read MoreAug 24, 2021
-
Research Snapshot: Researchers derive new cancer therapies to decrease the risk of heart damage
Following decades of worldwide research standstills on cancer drug improvement, Steven Townsend and his team of researchers synthesize cancer therapeutics that bypass toxicity aimed at heart health. Est. reading time: 2.5 minutes. Read MoreJul 29, 2021
-
Merrikh named finalist for Blavatnik National Award for Young Scientists for second year
For the second year in a row, Professor of Biochemistry Houra Merrikh has been named a finalist for the 2021 Blavatnik National Awards for Young Scientists in the life sciences category for her discovery of a potential solution to prevent the evolution of antimicrobial resistance and, in some cases, even reverse existing resistance. Read MoreJun 17, 2021
-
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Read MoreFeb 25, 2021
-
SARS-CoV-2 protein blocks an essential step in host gene expression, new discovery finds
Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. Read MoreFeb 17, 2021
-
Bruce Carter joins CMT Research Foundation scientific advisory board
Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation, which shapes research directions and therapeutic development of Charcot-Marie-Tooth disease. Read MoreFeb 12, 2021
-
Scientists discuss inclusion and equity in biomedical research at virtual event
Biomedical researchers across Vanderbilt University will convene to discuss the history and impact of Black biomedical scientists on Monday, Feb. 15, at noon CT. Read MoreFeb 9, 2021
-
Cortez named interim chair in the Department of Biochemistry; York named Impossible Foods chief science officer
David Cortez, Richard N. Armstrong Chair for Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1. This follows the departure of John York, who was recently named chief science officer of California-based food technology startup Impossible Foods. Read MoreDec 8, 2020
-
Kudos: Read about faculty, staff and student awards, appointments and achievements
Read about the latest faculty, staff and student awards, appointments and achievements. Read MoreNov 24, 2020
-
Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease
Further research by biochemistry professors Charles Sanders and Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research. Read MoreNov 17, 2020
-
Vanderbilt researchers work to build a molecular Trojan horse to battle COVID-19
Vanderbilt biochemists figure out how the little-understood Envelope protein helps SARS-CoV-2 function and how to disrupt the endogenously creative virus. Read MoreNov 17, 2020
-
Vanderbilt contributes to the ‘Google Earth’ of the human body, starting with the kidney
Vanderbilt contributes molecular imaging data of kidney to the Human BioMolecular Atlas Program, a consortium of 18 diverse collaborative research teams across the United States and Europe. Read MoreNov 12, 2020
-
Vanderbilt biologist uses rabies-like virus to illuminate how SARS-CoV-2 blocks immune response
Yi Ren, assistant professor of biochemistry, has contributed to research on the function and impact of the SARS-CoV-2 protein on immune signaling protein in host cells. This understanding may lead to the development of immune-enhancing therapeutics. Read MoreNov 9, 2020
-
Ren’s lab advances SARS-CoV-2 research and prioritizes safety during Research Ramp-up
Assistant Professor of Biochemistry Yi Ren and her team have made several discoveries to illuminate the mechanisms of key host-pathogen interactions involving viruses, with implications for gaining a better understanding of SARS-CoV-2, the virus that causes COVID-19. Read MoreNov 6, 2020
-
Vanderbilt biochemists reveal the cause of Charcot-Marie-Tooth disease—too much of a good thing
Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people. Read MoreOct 27, 2020
-
Interdisciplinary melanoma research brings understanding of cellular resistance to cancer treatment, opening doors to new cures
Drug-tolerant persister cells–those that survive cancer treatment–found to rely on similar survival mechanisms across cancers, in a groundbreaking study led by Vanderbilt researchers. Read MoreOct 21, 2020
-
Vanderbilt team works across disciplines to replicate cellular filament behavior for the first time, shedding new light on a fundamental cellular process
Cell biologists, physicists and computer scientists use computational modeling to pinpoint the components that shape cell behavior. Read MoreSep 8, 2020
-
Discovery of natural compound may help fend off antibiotic resistance of hard-to-treat infections
A bifunctional natural compound has been discovered with the potential to make antibiotic resistance to deadly infections less likely. Read MoreAug 19, 2020
-
Vanderbilt researcher Houra Merrikh named a finalist of the 2020 Blavatnik National Awards for Young Scientists, inducted to New York Academy of Sciences
Biochemist Houra Merrikh has been named one of the nation’s rising stars in science for her work to reverse antimicrobial resistance. Read MoreJun 17, 2020
-
Stanley Cohen, Vanderbilt biochemist who won Nobel Prize, has died
Stanley Cohen, a legendary Vanderbilt University biochemist who was awarded the Nobel Prize for the discovery of epidermal growth factor and its receptor, died on Feb. 5 at the age of 97. Read MoreFeb 6, 2020